Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
Atopic dermatitis (AD) is a clinically heterogenous, inflammatory skin condition with a high impact on patients’ daily activities that remains difficult to treat. The knowledge acquired over the last decade on AD pathophysiology and disease burden led to the development of new targeted therapeutic...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Mattioli1885
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/f2263195ebd44087a6390424e7c41784 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|